EnteroMedics Inc. (NASDAQ:ETRM) saw a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 718,396 shares, a decrease of 38.3% from the January 13th total of 1,164,610 shares. Approximately 17.0% of the company’s stock are sold short. Based on an average daily trading volume, of 5,003,613 shares, the days-to-cover ratio is presently 0.1 days.
Shares of EnteroMedics (NASDAQ:ETRM) opened at 7.69 on Tuesday. EnteroMedics has a one year low of $0.04 and a one year high of $30.41. The firm’s 50-day moving average price is $7.87 and its 200 day moving average price is $1.98. The firm’s market cap is $12.43 million.
Separately, S&P Equity Research cut their price target on EnteroMedics from $17.19 to $11.06 in a report on Monday, January 9th.
“EnteroMedics Inc. (ETRM) Short Interest Down 38.3% in January” was originally reported by sleekmoney and is owned by of sleekmoney. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark law. The legal version of this piece can be read at http://sleekmoney.com/enteromedics-inc-etrm-short-interest-down-38-3-in-january/1659243.html.
EnteroMedics Inc (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company’s neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve.
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/enteromedics-inc-etrm-short-interest-down-38-3-in-january/1659243.html
Receive News & Ratings for EnteroMedics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EnteroMedics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.